Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
4.390
-0.130 (-2.88%)
At close: Apr 28, 2026, 4:00 PM EDT
4.620
+0.230 (5.24%)
After-hours: Apr 28, 2026, 7:54 PM EDT
Prelude Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -99.5 | -127.17 | -121.83 | -115.44 | -111.69 | |
| Depreciation & Amortization | 1.71 | 1.77 | 1.17 | 1.32 | 0.92 | |
| Loss (Gain) From Sale of Investments | -0.37 | -4.64 | -3.47 | 2.59 | 1.36 | |
| Stock-Based Compensation | 11.91 | 21.35 | 25.62 | 25.14 | 20.93 | |
| Other Operating Activities | 1.53 | 1.59 | 1.94 | 1.72 | 1.33 | |
| Change in Accounts Payable | -3.92 | 3.31 | -2.27 | -0.35 | 3.9 | |
| Change in Unearned Revenue | 35.53 | - | - | - | - | |
| Change in Other Net Operating Assets | -3.21 | 0.91 | -8.21 | 1.28 | -0.28 | |
| Operating Cash Flow | -56.3 | -102.89 | -107.06 | -83.73 | -83.53 | |
| Capital Expenditures | -0.07 | -0.76 | -3.51 | -3.02 | -2.32 | |
| Investment in Securities | 53.53 | 90.96 | -31.13 | 84.71 | -261.48 | |
| Investing Cash Flow | 53.46 | 90.19 | -34.65 | 81.69 | -263.8 | |
| Long-Term Debt Repaid | -0.21 | -0.4 | - | - | - | |
| Net Debt Issued (Repaid) | -0.21 | -0.4 | - | - | - | |
| Issuance of Common Stock | 25.04 | 0.44 | 136.41 | 0.82 | 165.2 | |
| Repurchase of Common Stock | -0.02 | -0.05 | -0.02 | - | - | |
| Other Financing Activities | - | -0.11 | - | - | -0.3 | |
| Financing Cash Flow | 24.82 | -0.12 | 136.4 | 0.82 | 164.9 | |
| Net Cash Flow | 21.97 | -12.82 | -5.31 | -1.22 | -182.44 | |
| Free Cash Flow | -56.37 | -103.65 | -110.58 | -86.75 | -85.85 | |
| Free Cash Flow Margin | -464.32% | -1480.74% | - | - | - | |
| Free Cash Flow Per Share | -0.73 | -1.37 | -1.83 | -1.83 | -1.86 | |
| Levered Free Cash Flow | -23.87 | -62 | -58.93 | -50.12 | -46.86 | |
| Unlevered Free Cash Flow | -23.87 | -62 | -58.93 | -50.12 | -46.86 | |
| Change in Working Capital | 28.41 | 4.22 | -10.48 | 0.93 | 3.63 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.